XML 53 R37.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Provision for income taxes
Income tax expense for continuing operations consisted of the following:
Year Ended December 31,
202220212020
(In millions)
Current:
Federal$297 $209 $281 
State40 31 26 
Total current337 240 307 
Deferred:
Federal(66)(17)(13)
State— (7)(7)
Foreign— — 
Total deferred(66)(24)(19)
Income tax expense$271 $216 $288 
Effective income tax rate reconciliation to the statutory federal income tax rate
A reconciliation of the U.S. federal statutory income tax rate to the combined effective income tax rate for continuing operations is as follows:
Year Ended December 31,
202220212020
Statutory federal tax (benefit) rate21.0 %21.0 %21.0 %
State income provision (benefit), net of federal benefit3.0 2.2 1.6 
Nondeductible health insurer fee (“HIF”)— — 6.1 
Nondeductible compensation1.8 1.5 1.1 
Other(0.3)— 0.2 
Effective tax expense rate25.5 %24.7 %30.0 %
Significant components of deferred tax assets and liabilities Significant components of our deferred tax assets and liabilities as of December 31, 2022 and 2021 were as follows:
December 31,
20222021
(In millions)
Accrued expenses and reserve liabilities$96 $57 
Other accrued medical costs24 23 
Net operating losses13 
Unearned premiums16 17 
Lease financing obligation40 
Unrealized losses49 
Fixed assets and intangibles— 
Tax credit carryover
Other
Valuation allowance(18)(10)
Total deferred income tax assets, net of valuation allowance 235 120 
Fixed assets and intangibles— (1)
Prepaid expenses (15)(13)
Total deferred income tax liabilities (15)(14)
Net deferred income tax asset$220 $106 
Unrecognized tax benefits roll forward
The roll forward of our unrecognized tax benefits is as follows:
Year Ended December 31,
202220212020
(In millions)
Gross unrecognized tax benefits at beginning of period$(15)$(20)$(20)
Settlements — — 
Lapse in statute of limitations10 — — 
Gross unrecognized tax benefits at end of period$(5)$(15)$(20)